Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine
CompletedOBSERVATIONAL
Enrollment
334
Participants
Timeline
Start Date
March 29, 2016
Primary Completion Date
April 27, 2016
Study Completion Date
April 27, 2016
Conditions
Dengue FeverDengue Haemorrhagic Fever
Trial Locations (1)
70000
Investigational Site, Ratchaburi
All Listed Sponsors
lead
Sanofi Pasteur, a Sanofi Company
INDUSTRY
NCT02827162 - Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue Vaccine | Biotech Hunter | Biotech Hunter